Blog
Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M
On Jan. 22, 2026, Fairmount Funds Management LLC, a Director at Cogent Biosciences (NASDAQ:COGT), reported the indirect sale of 3,500,000 shares for a total of apporximately $127.4 million
Should You Buy Nio Stock While It's Below $5 a Share?
The Chinese auto market is enormous. It comprised 30% of all global auto sales in 2025 and it positively dwarfs the next four largest markets -- the U.S. at 18% of all sales, India and Japan at
This Nearly 4%-Yielding Energy Stock Delivered Powerful Growth in 2025 With More to Come in 2026 and Beyond
Last year was a very strong year for Brookfield Renewable (NYSE: BEPC)(NYSE: BEP). The global renewable energy company delivered record financial results and made significant progress in securing
Enliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500k
Chief Scientific Officer Joseph P. Lyssikatos disposed of 20,000 shares of Enliven Therapeutics (NASDAQ:ELVN) in multiple open-market transactions on Jan. 20, 2026, for a total consideration of
Protagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover Taxes
Arturo Molina, Chief Medical Officer of Protagonist Therapeutics (NASDAQ:PTGX), directly sold 9,514 shares in an open-market transaction on Jan. 20, 2026, for an approximate value of $784,700
1 Underrated Reason Netflix's Growth Story Isn't Over
Netflix's (NASDAQ: NFLX) share prices have trended downward, for the most part, over the past six months. The company is dealing with several headwinds, including a recent earnings report that
3 AI Stocks to Buy in 2026 and Hold Forever
Finding artificial intelligence (AI) stocks with the intention of buying now and holding forever is a wise idea. There may be some companies that rise and fall, but I think these three have serious
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million
On Jan. 15 and Jan. 16, 2026, Joshua B Cohen, Co-Chief Executive Officer of Amylyx Pharmaceuticals (NASDAQ:AMLX), executed an exercise of 200,000 stock options and sold 138,167 shares in open-market
Costco Stock Is Soaring. Is It Too Late to Buy?
Costco Wholesale (NASDAQ: COST) has outperformed the S&P 500 by a wide margin over a long period of time, but even some of the best stocks have off years, and Costco stock barely moved last year.
The AI Bubble Narrative Just Got Flipped On Its Head. Here's What Investors Need To Know.
Not long after the AI boom kicked off, talk of a bubble ensued.
It makes sense. The similarities to the dot-com era are too hard to ignore. Stocks are soaring on the back of another revolutionary
4 Ways to Set Your 401(k) Up for Success in 2026
Saving in a 401(k) could be one of the best financial decisions you'll ever make. You'll need money in retirement to supplement your Social Security. So the larger a 401(k) balance you have, the
Investment Firm Bouvel Raised Its Stake in This ETF by $8 Million. Is It a Buy?
Bouvel Investment Partners, LLC disclosed in a January 22, 2026, SEC filing that it purchased 85,742 additional shares of PIMCO Active Bond Exchange-Traded Fund (NYSE:BOND), during the fourth
Forget BigBear.ai: This Mission‑Critical AI Platform With Exploding Commercial Revenue Is the Better Long‑Term Bet
BigBear.ai (NYSE: BBAI) has lately been popular among investors looking to buy artificial intelligence (AI) software stocks at reasonable valuations. That's not too surprising, as the company seems
Harmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800
Sandip Kapadia, Chief Financial Officer of Harmony Biosciences (NASDAQ:HRMY), executed an open-market sale of 20,961 directly held shares on Jan. 15, 2026, fully exiting direct equity ownership
2 Financial Stocks Poised for a Comeback in 2026
The S&P 500 (SNPINDEX: ^GSPC) is up 14.9% over the last year, but payment processors Mastercard (NYSE: MA) and Visa (NYSE: V) are down slightly. Both stocks have sold off so far in 2026 as
2 High-Flying Electric Vehicle Stocks Have Serious Momentum -- But Are They Buys?
2025 wasn't an easy year for investors within the electric vehicle (EV) industry. The U.S. government administration rolled back incentives such as the $7,500 federal EV tax credit, added tariffs to
Arcellx Director Sells 6,000 Shares for $450,000
On Jan. 20, 2026, Director David Charles Lubner executed the exercise and immediate sale of 6,000 shares of Arcellx, Inc. (NASDAQ:ACLX) common stock for a total transaction value of approximately
Is This Fixed Income ETF a Buy After Symmetry Partners Initiated a Large Position Valued at Nearly $134 Million?
According to an SEC filing dated January 27, 2026, Symmetry Partners, LLC initiated a new position in the Dimensional Global Core Plus Fixed Income ETF (NASDAQ:DFGP), accumulating 2,471,670 shares
OneStream's Chief Revenue Officer Exercises Over 100k Shares as Share Prices Soar In January
On Jan. 16, 2026, Ken Hohenstein, Chief Revenue Officer of OneStream (NASDAQ:OS), exercised 120,000 stock options and immediately sold the resulting shares in an open-market transaction valued at
This Ivy League School Purchased Over 100k Shares of Chime
According to a SEC filing dated Jan. 30, 2026, Brown University initiated a new position in Chime Financial (NASDAQ:CHYM) by acquiring 102,805 shares. The estimated transaction value was
The Behind-the-Scenes Monopoly Powering the Tech Industry
In all the talk about artificial intelligence (AI) and semiconductors, there's one company that I don't see mentioned often despite the fact that the entire technology industry is reliant upon its
Obermeyer Loads Up On 187K TBIL Shares As the ETF May Soon Be Tokenized
According to an SEC filing dated Jan. 28, 2026, Obermeyer Wealth Partners increased its stake in F/m U.S. Treasury 3 Month Bill ETF (NASDAQ:TBIL) by 186,777 shares. The estimated transaction value
2 AI Stocks Trading at Bargain Prices to Kick Off 2026
You might expect artificial intelligence (AI) stocks to trade for exorbitant prices these days, considering their popularity over the past couple of years. Investors have piled into AI players --
Should This Trillion-Dollar "Magnificent Seven" Stock Spend $3 Billion and Buy Peloton?
Peloton (NASDAQ: PTON) shares are currently trading 97% below their peak (as of Jan. 29), a high-water mark that was hit when the business was experiencing incredible demand for its tech-enhanced



